Welcome to our dedicated page for Orchid Is Cap SEC filings (Ticker: ORC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing Orchid Island Capital’s mortgage-REIT disclosures often means wading through hedge tables, leverage footnotes, and pages of prepayment data. If you have ever searched for “Orchid Island Capital insider trading Form 4 transactions” or wondered where the company reveals its latest swap positions, you know the challenge. Stock Titan’s AI-powered layer turns those dense filings into clear, actionable snapshots—so you can see leverage ratios, CPR trends, and dividend clues in minutes, not hours.
Every SEC form is covered and updated the moment it hits EDGAR. Want the “Orchid Island Capital quarterly earnings report 10-Q filing”? We surface segment yields, funding costs, and book-value changes instantly. Need an “Orchid Island Capital 8-K material events explained”? Our summaries flag capital raises or management shifts, while real-time alerts track “Orchid Island Capital Form 4 insider transactions real-time”—highlighting how executives adjust positions when interest-rate curves move.
What investors do here:
- Compare swap duration tables across quarters with our “Orchid Island Capital earnings report filing analysis”.
- Read an “Orchid Island Capital annual report 10-K simplified” to grasp hedging strategy and dividend risk.
- Dive into the “Orchid Island Capital proxy statement executive compensation” to link pay with performance metrics.
- Monitor “Orchid Island Capital executive stock transactions Form 4” before ex-dividend dates.
- Use “understanding Orchid Island Capital SEC documents with AI” to translate complex duration gaps into plain language.
Orchid Island Capital, Inc. (NYSE: ORC) filed a Rule 424(b)(5) prospectus supplement to expand its at-the-market (“ATM”) equity program. The February 24 2025 agreement originally authorized up to $350 million; a July 28 2025 amendment raises the total to $500 million. To date ORC has sold 34,517,584 shares for $266.5 million of gross proceeds, leaving $233.5 million available.
Sales may be made through J.P. Morgan, BTIG, Citizens JMP and JonesTrading as Agents on a best-efforts “at-the-market” basis or via negotiated transactions. Agents earn up to 2.0 % of gross proceeds; expenses are estimated at $200 k. Net proceeds will be added to general funds for additional Agency RMBS purchases, debt repayment or other corporate purposes.
The filing restates key risk factors: dilution, share-price volatility, interest-rate sensitivity and broad Manager discretion over proceeds. Updated tax disclosure reflects the “One Big Beautiful Bill Act,” including (i) TRS asset cap raised to 25 % after 2025 and (ii) permanent 20 % deduction for qualified REIT dividends. Ownership restrictions remain at 9.8 % to preserve REIT status.
ORC continues to target attractive risk-adjusted returns through leveraged investments in pass-through and structured Agency RMBS while maintaining REIT and Investment Company Act exemptions.
Orchid Island Capital, Inc. (ORC) – Form 4 insider transaction dated 06/26/2025
Chief Financial Officer and Director G. Hunter Haas IV reported the vesting and settlement of previously granted Performance Units under the company’s 2021–2023 Long-Term Equity Incentive Plans.
- Shares acquired: 3,755 common shares were issued at a conversion price of $0 following the vesting of three separate Performance Unit awards (original grant dates: 03/28/2022, 04/13/2023 and 03/19/2024).
- Shares withheld for taxes: 1,403 shares were automatically surrendered to the issuer at the 06/25/2025 closing price of $7.01 to satisfy statutory withholding.
After the transactions, Haas directly owns 73,702 ORC common shares (an increase of 2,352 shares, or +3.3% versus pre-transaction holdings) and retains 16,882.83 unexercised Performance Units.
The activity reflects routine equity-award vesting rather than open-market buying; nonetheless, the net increase slightly aligns executive incentives with shareholders. No cash proceeds were received by the insider other than the shares withheld for tax settlement. There are no indications of option exercises, open-market sales, or material changes to corporate strategy within this filing.
FAQ
What is the current stock price of Orchid Is Cap (ORC)?
What is the market cap of Orchid Is Cap (ORC)?
